Abstract:Abstract Motivation Identification and interpretation of non-coding variations that affect disease risk remain a paramount challenge in genome-wide association studies (GWAS) of complex diseases. Experimental efforts have provided comprehensive annotations of functional elements in the human genome. On the other hand, advances in computational biology, especially machine learning approaches, have facilitated accurate predictions of cell-type-specific functional annotations. Integrating functional annotations with GWAS signals has advanced the understanding of disease mechanisms. In previous studies, functional annotations were treated as static of a genomic region, ignoring potential functional differences imposed by different genotypes across individuals. Results We develop a computational approach, Openness Weighted Association Studies (OWAS), to leverage and aggregate predictions of chromosome accessibility in personal genomes for prioritizing GWAS signals. The approach relies on an analytical expression we derived for identifying disease associated genomic segments whose effects in the etiology of complex diseases are evaluated. In extensive simulations and real data analysis, OWAS identifies genes/segments that explain more heritability than existing methods, and has a better replication rate in independent cohorts than GWAS. Moreover, the identified genes/segments show tissue-specific patterns and are enriched in disease relevant pathways. We use rheumatic arthritis and asthma as examples to demonstrate how OWAS can be exploited to provide novel insights on complex diseases. Availability and implementation The R package OWAS that implements our method is available at https://github.com/shuangsong0110/OWAS. Supplementary information Supplementary data are available at Bioinformatics online.

Disease category-specific annotation of variants using an ensemble learning framework

Novel Association Strategy with Copy Number Variation for Identifying New Risk Loci of Human Diseases

Openness weighted association studies: leveraging personal genome information to prioritize non-coding variants

Identifying noncoding risk variants using disease-relevant gene regulatory networks

DYNA: Disease-Specific Language Model for Variant Pathogenicity

A method for scoring the cell type-specific impacts of noncoding variants in personal genomes

Integrating sequence conservation features and a domain-domain interaction network to detect disease-associated nsSNPs

Systematic Localization of Common Disease-Associated Variation in Regulatory DNA

Computational Assessment of the Regulation-Modulating Potential for Noncoding Variants

VannoPortal: multiscale functional annotation of human genetic variants for interrogating molecular mechanism of traits and diseases

A framework to decipher the genetic architecture of combinations of complex diseases: applications in cardiovascular medicine

Computational Assessment of the Expression-modulating Potential for Non-coding Variants.

A comprehensive investigation of statistical and machine learning approaches for predicting complex human diseases on genomic variants

Extraction of Sequence Conservation Features for the Prioritization of Candidate Single Amino Acid Polymorphisms

Prediction of disease-associated functional variants in noncoding regions through a comprehensive analysis by integrating datasets and features

In silico generation and augmentation of regulatory variants from massively parallel reporter assay using conditional variational autoencoder

Searching Genome-Wide Multi-Locus Associations for Multiple Diseases Based on Bayesian Inference.

Identifying Disease Related Sub-Pathways for Analysis of Genome-Wide Association Studies

Supervised Learning-Based Tagsnp Selection for Genome-Wide Disease Classifications

GWAS4D: multidimensional analysis of context-specific regulatory variant for human complex diseases and traits

Prioritisation of Candidate Single Amino Acid Polymorphisms Using One-Class Learning Machines.